Among lymph node-positive patients ( n = 36), MonarchE inclusion criteria (15) were not associated with a higher RS ( p = 0.61), and HER2-low did not reach statistical significance.
← all excerpts
The role of modern parameters and their relationship with recurrence risk as assessed by Oncotype DX: real-world evidence.
1
—
—